闫福岭
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Neurology 12
- Neuroinflammation and Neurodegeneration Mechanisms 7
- Neurological Disease Mechanisms and Treatments 5
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 4
- Co-authors
- Lei Zuo (10 shared papers)Zhi-Jun Zhang (3 shared papers)Fengdi Zhao (1 shared paper)Ying Zheng (1 shared paper)Qiwen Deng (6 shared papers)Hanqing Zhang (4 shared papers)Zhengtian Gu (4 shared papers)Lili Xie (1 shared paper)
- Journals
- European Journal of Neurology (3 papers)Journal of Neuroinflammation (3 papers)Frontiers in Neurology (3 papers)Stroke (2 papers)Clinical Science (1 paper)
- Partner nations
- ChinaBangladesh
In The Last Decade
闫福岭
39 papers receiving 1.1k citations
闫福岭's Hit Papers
Peers
Comparison fields: 5 of 92
- Neurology 277
- Cancer Research 197
- Biological Psychiatry 30
- Neurology 80
- Molecular Biology 375
Countries citing papers authored by 闫福岭
This map shows the geographic impact of 闫福岭's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by 闫福岭 with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites 闫福岭 more than expected).
Fields of papers citing papers by 闫福岭
This network shows the impact of papers produced by 闫福岭. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by 闫福岭. The network helps show where 闫福岭 may publish in the future.
Co-authors
The 25 scholars most cited alongside 闫福岭, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke Hit paper breakdown → | 2021 | 203 |
| 2 | 2019 | 122 | |
| 3 | 2022 | 75 | |
| 4 | 2023 | 63 | |
| 5 | 2008 | 57 | |
| 6 | 2018 | 49 | |
| 7 | 2016 | 45 | |
| 8 | 2018 | 43 | |
| 9 | 2022 | 43 | |
| 10 | 2016 | 37 | |
| 11 | 2009 | 35 | |
| 12 | 2016 | 30 | |
| 13 | 2021 | 30 | |
| 14 | 2023 | 28 | |
| 15 | 2018 | 25 | |
| 16 | 2023 | 23 | |
| 17 | 2016 | 21 | |
| 18 | 2018 | 20 | |
| 19 | 2020 | 19 | |
| 20 | 2020 | 19 |
About 闫福岭
闫福岭 is a scholar working on Neurology, Cancer Research, Epidemiology, Rehabilitation and Clinical Biochemistry, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Circular RNAs in diseases (6 papers), Acute Ischemic Stroke Management (6 papers), Neurological Disease Mechanisms and Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Stroke Rehabilitation and Recovery (3 papers). The work is most often cited by research in Neurology (277 citations), Cancer Research (197 citations), Biological Psychiatry (30 citations), Neurology (80 citations) and Molecular Biology (375 citations) 闫福岭 has collaborated with scholars based in China and Bangladesh. Frequent co-authors include Lei Zuo, Zhi-Jun Zhang, Fengdi Zhao, Ying Zheng, Qiwen Deng, Hanqing Zhang, Zhengtian Gu, Lili Xie, Huiqing Wang and Huiling Sun. Their work appears in journals such as European Journal of Neurology, Journal of Neuroinflammation, Frontiers in Neurology, Stroke and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.